Moleculin Biotech Inc. (MBRX)
NASDAQ · Healthcare
Moleculin Biotech Inc. Total Liabilities 2016–2025
Moleculin Biotech Inc. annual/quarterly total liabilities history from 2016 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Moleculin Biotech Inc. total liabilities for the quarter ending December 31, 2025 were 7.1M, a 24.54% increase year-over-year.
- Moleculin Biotech Inc. total liabilities for 2025 were 7.1M, a 24.54% increase from 2024.
- Moleculin Biotech Inc. total liabilities for 2024 were 5.7M, a 52.92% decrease from 2023.
- Moleculin Biotech Inc. total liabilities for 2023 were 12.1M, a 132.15% increase from 2022.
- Moleculin Biotech Inc. total liabilities for 2022 were 5.2M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Moleculin Biotech Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $7 |
| 2024 | $6 |
| 2023 | $12 |
| 2022 | $5 |
| 2021 | $5 |
| 2020 | $11 |
| 2019 | $10 |
| 2018 | $5 |
| 2017 | $2 |
| 2016 | $1 |
| Moleculin Biotech Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $7 |
| 2024-12-31 | $6 |
| 2023-12-31 | $12 |
| 2022-12-31 | $5 |
| 2021-12-31 | $5 |
| 2020-12-31 | $11 |
| 2019-12-31 | $10 |
| 2018-12-31 | $5 |
| 2017-12-31 | $2 |
| 2016-12-31 | $1 |
Moleculin Biotech Inc. Total Liabilities — FAQ
Moleculin Biotech Inc. (MBRX) total liabilities over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MBRX's total liabilities history?
The chart and table above show Moleculin Biotech Inc.'s total liabilities by year and by quarter, including the growth rate.